Research map: Real-world effectiveness and safety of lebrikizumab in adults with moderate-to-severe atopic dermatitis: a retrospective observational study with focus on head and neck involvement

Back to the article

Papers in this map

  1. Atopic dermatitis · Stephan Weidinger · 2018 · 1538 citations · Cited by this paper
  2. Complete remission of keratosis lichenoides chronica with abrocitinib · 2026 · Related
  3. Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis · Jonathan I. Silverberg · 2023 · 343 citations · Cited by this paper
  4. Unilateral facial flushing and anhidrosis: a case of idiopathic Harlequin syndrome with successful botulinum toxin treatment · 2026 · Related
  5. Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE) · Eric Lawrence Simpson · 2018 · 332 citations · Cited by this paper
  6. Atypical chronic leg ulcers revealing pancreatic panniculitis associated with pancreatic adenocarcinoma · 2026 · Related
  7. Update on the Pathogenesis and Therapy of Atopic Dermatitis · Huaguo Li · 2021 · 285 citations · Cited by this paper
  8. Cold-induced cutaneous smooth muscle hamartoma · 2026 · Related
  9. Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: 52-week results of two randomized double-blinded placebo-controlled phase III trials · Andrew Blauvelt · 2023 · 164 citations · Cited by this paper
  10. Azathioprine-induced acute generalized exanthematous pustulosis in a woman with autoimmune hepatitis · 2026 · Related
  11. Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis · Eric Lawrence Simpson · 2023 · 153 citations · Cited by this paper
  12. Could an intra-procedural dermoscopic approach be necessary for obtaining radical treatment of actinic keratosis cancerization field if combined with ablative CO2 laser? · 2026 · Related
  13. Therapeutic Impact and Management of Persistent Head and Neck Atopic Dermatitis in Dupilumab-Treated Patients · Andrea Chiricozzi · 2021 · 26 citations · Cited by this paper
  14. Morbihan disease in an Asian patient: diagnostic and therapeutic challenges · 2026 · Related
  15. Lebrikizumab Provides Rapid Clinical Responses Across All Eczema Area and Severity Index Body Regions and Clinical Signs in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis · Eric Lawrence Simpson · 2024 · 17 citations · Cited by this paper
  16. Full-length 16S rRNA metabarcoding characterization of facial skin microbiota in acne patients: a case study in the Mekong Delta of Viet Nam · 2026 · Related
  17. Effectiveness, Safety, and Health-Related Quality of Life in Moderate-to-Severe Atopic Dermatitis Treated with Lebrikizumab: A 16-Week Nationwide Retrospective Cohort Study · Gianluca Avallone · 2025 · 14 citations · Cited by this paper
  18. Effectiveness and safety of topical L-ascorbic acid 15% serum compared to retinol 0.1% serum for skin aging: a double-blind randomized controlled trial study · 2026 · Related
  19. 24-Week Real-World Effectiveness and Safety of Lebrikizumab for Atopic Dermatitis in Japan: An Analysis Stratified by Prior Systemic Therapy · Teppei Hagino · 2025 · 12 citations · Cited by this paper
  20. Comparative analysis of Curcuma longa (curcumin) and fusidic acid on the antimicrobial susceptibility of Staphylococcus aureus and Streptococcus pyogenes in impetigo · 2026 · Related
  21. Letter: Real-World Japanese Study of the Effectiveness and Safety of Switching From Dupilumab to Lebrikizumab in Patients with Moderate to Severe Atopic Dermatitis · Teppei Hagino · 2025 · 6 citations · Cited by this paper

Source: OpenAlex (CC0)